New England Journal of Medicine.
Terlipressin is an investigational product and its safety and effectiveness have not yet been established by the U.S. Food and Drug Administration (FDA) or Health Canada.
As previously announced, the Phase 3 CONFIRM study met its primary endpoint of Verified HRS Reversal, which is defined as renal function improvement, avoidance of dialysis and short-term survival. The main objective of the CONFIRM study was to assess the efficacy and safety of terlipressin, together with albumin, versus placebo in adults in the U.S. and Canada with cirrhosis and HRS-1. The trial met three of the four pre-specified secondary endpoints of the study including HRS reversal,
Sowmya Tejha Kandregula joins as Chairman – Advisory Board to IJMRA
Sowmya Tejha Kandregula joins as Chairman – Advisory Board to International Journals of the Multidisciplinary Research Academy - IJMRA INDIA, January 21, 2021 /EINPresswire.com/ International Journals of the Multidisciplinary Research Academy – IJMRA, the world’s most prominent open access publication, today announced that Mr. Sowmya Tejha Kandregula, a seasoned Data Governance and Data Privacy leader, has been promoted to Chairman – Advisory Board. His appointment is effective from January 15th, 2021. He has been a long serving Chief Advisors on the advisory board. As the Chairman – Advisory Board, Mr. Kandregula will provide overall direction and guidance to the advisory board specifically with regard to advocating journals at global conferences, endorsing paper acceptance/rejection approvals, advancing quality control procedures, recommending elevated-qualit